TipRanks
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market
LEXT
Lexston Life Sciences Corp.
RESEARCH TOOLSreports
Want to see TSE:LEXT full AI Analyst Report?

Lexston Life Sciences Corp. (LEXT) Financial Statements

6 Followers

Lexston Life Sciences Corp. Financial Overview

Lexston Life Sciences Corp.'s market cap is currently C$1.31M. The company's EPS TTM is C$-0.0673; its P/E ratio is -0.74; Lexston Life Sciences Corp. is scheduled to report earnings on October 14, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 26Aug 25Aug 24May 23Aug 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 361.01K
Gross ProfitC$ 0.00C$ 0.00C$ -26.39KC$ -29.80KC$ 241.49K
Operating IncomeC$ -1.35MC$ -1.35MC$ -674.72KC$ -871.53KC$ -2.00M
EBITDAC$ -1.35MC$ -1.51MC$ -648.32KC$ -841.73KC$ -2.29M
Net IncomeC$ -1.42MC$ -1.62MC$ -867.71KC$ -1.11MC$ -2.32M
Balance Sheet
Cash & Short-Term InvestmentsC$ 126.52KC$ 2.32KC$ 390.40KC$ 511.00KC$ 590.49K
Total AssetsC$ 891.25KC$ 279.49KC$ 750.95KC$ 814.30KC$ 952.80K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -126.52KC$ -2.32KC$ -390.40KC$ -511.00KC$ -590.49K
Total LiabilitiesC$ 149.23KC$ 208.82KC$ 39.87KC$ 11.21KC$ 79.09K
Stockholders' EquityC$ 742.02KC$ 70.67KC$ 711.08KC$ 803.10KC$ 873.71K
Cash Flow
Free Cash FlowC$ -1.10MC$ -1.19MC$ -723.16KC$ -987.74KC$ -1.40M
Operating Cash FlowC$ -1.10MC$ -1.19MC$ -523.18KC$ -987.74KC$ -1.40M
Investing Cash FlowC$ -61.26KC$ -10.00KC$ -199.99KC$ 0.00C$ -109.97K
Financing Cash FlowC$ 1.29MC$ 814.66KC$ 602.57KC$ 908.24KC$ 1.15M
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

Income Statement >

Lexston Life Sciences Corp. Debt to Assets

Balance Sheet >

Lexston Life Sciences Corp. Cash Flow

Cash Flow >

Lexston Life Sciences Corp. Forecast EPS vs Actual EPS

Earnings >